Clinical trials lasting 68 weeks showed that participants on semaglutide maintained significant weight loss throughout the treatment period, with continued improvements in metabolic markers including blood sugar, blood pressure, and cholesterol levels
Berberine is generally well-tolerated at standard doses (1,000-1,500mg daily), but carries important considerations: Common side effects: Gastrointestinal upset (cramping, diarrhea, constipation) in 10-30% of users, typically resolving within 2-4 weeks 43 Yin, J
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
CDC explains protection may decrease over time in some groups
The medication also delayed gastric emptying and reduced plasma alanine and glucagon release